TipRanks
Enzychem Lifesciences Corp. (KR:183490)
:183490
South Korea Market
183490
Enzychem Lifesciences Corp.
RESEARCH TOOLSreports

Enzychem Lifesciences Corp. (183490) Ratios

― Followers

Enzychem Lifesciences Corp. Ratios

KR:183490's free cash flow for Q4 2025 was ₩0.04. For the 2025 fiscal year, KR:183490's free cash flow was decreased by ₩ and operating cash flow was ₩-0.71. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 14.06 14.06 13.03 12.33 5.21
Quick Ratio
 12.62 12.62 11.97 11.27 4.98
Cash Ratio
 0.95 0.95 0.91 1.09 0.18
Solvency Ratio
 -1.53 -1.53 -0.92 -0.34 -0.50
Operating Cash Flow Ratio
 -1.34 -1.34 -0.05 -0.72 -0.34
Short-Term Operating Cash Flow Coverage
 -3.40 -3.40 -0.15 -3.02 -0.40
Net Current Asset Value
₩ 105.95B₩ 105.95B₩ 127.97B₩ 157.56B₩ 174.50B
Leverage Ratios
Debt-to-Assets Ratio
 0.03 0.03 0.03 0.03 0.15
Debt-to-Equity Ratio
 0.04 0.04 0.03 0.03 0.19
Debt-to-Capital Ratio
 0.03 0.03 0.03 0.03 0.16
Long-Term Debt-to-Capital Ratio
 <0.01 <0.01 0.00 <0.01 <0.01
Financial Leverage Ratio
 1.08 1.08 1.13 1.09 1.23
Debt Service Coverage Ratio
 -2.44 -4.29 -4.51 -1.31 -0.27
Interest Coverage Ratio
 -64.11 -64.96 -55.27 -23.15 -1.46
Debt to Market Cap
 0.03 0.03 0.03 0.03 0.34
Interest Debt Per Share
 65.07 65.07 64.95 74.03 724.85
Net Debt to EBITDA
 0.35 0.20 0.29 1.71 -2.29
Profitability Margins
Gross Profit Margin
4.99%4.99%5.57%5.72%9.07%
EBIT Margin
-16.07%-26.62%-28.23%-12.18%-58.38%
EBITDA Margin
-12.61%-22.00%-23.76%-7.56%-49.41%
Operating Profit Margin
-19.06%-19.32%-17.05%-18.88%-55.04%
Pretax Profit Margin
-26.92%-26.92%-28.54%-12.99%-96.03%
Net Profit Margin
-26.76%-26.76%-28.57%-12.27%-94.20%
Continuous Operations Profit Margin
-26.71%-26.70%-28.55%-12.37%-94.20%
Net Income Per EBT
99.41%99.41%100.10%94.41%98.09%
EBT Per EBIT
141.22%139.37%167.38%68.81%174.48%
Return on Assets (ROA)
-12.20%-12.20%-12.16%-4.41%-10.14%
Return on Equity (ROE)
-12.16%-13.18%-13.79%-4.82%-12.44%
Return on Capital Employed (ROCE)
-9.20%-9.32%-7.74%-7.27%-7.14%
Return on Invested Capital (ROIC)
-8.89%-9.01%-7.54%-6.78%-5.95%
Return on Tangible Assets
-12.53%-12.53%-12.52%-4.53%-10.23%
Earnings Yield
-13.69%-13.99%-16.77%-5.76%-22.99%
Efficiency Ratios
Receivables Turnover
 7.22 7.22 4.39 3.76 2.58
Payables Turnover
 47.76 47.76 29.06 11.04 16.19
Inventory Turnover
 5.42 5.42 6.03 4.80 2.47
Fixed Asset Turnover
 3.54 3.54 3.20 2.91 1.14
Asset Turnover
 0.46 0.46 0.43 0.36 0.11
Working Capital Turnover Ratio
 0.57 0.55 0.52 0.45 0.23
Cash Conversion Cycle
 110.28 110.28 131.18 140.03 266.35
Days of Sales Outstanding
 50.56 50.56 83.22 97.00 141.31
Days of Inventory Outstanding
 67.36 67.36 60.51 76.09 147.59
Days of Payables Outstanding
 7.64 7.64 12.56 33.06 22.54
Operating Cycle
 117.92 117.92 143.74 173.09 288.90
Cash Flow Ratios
Operating Cash Flow Per Share
 -142.17 -142.17 -7.28 -120.99 -217.11
Free Cash Flow Per Share
 -152.23 -152.23 -13.49 -148.14 -338.59
CapEx Per Share
 10.06 10.06 6.21 27.16 121.48
Free Cash Flow to Operating Cash Flow
 1.07 1.07 1.85 1.22 1.56
Dividend Paid and CapEx Coverage Ratio
 -14.13 -14.13 -1.17 -4.46 -1.79
Capital Expenditure Coverage Ratio
 -14.13 -14.13 -1.17 -4.46 -1.79
Operating Cash Flow Coverage Ratio
 -2.28 -2.28 -0.12 -1.81 -0.38
Operating Cash Flow to Sales Ratio
 -0.16 -0.16 >-0.01 -0.13 -0.54
Free Cash Flow Yield
-9.10%-9.10%-0.81%-7.76%-20.46%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -7.33 -7.15 -5.96 -17.36 -4.35
Price-to-Sales (P/S) Ratio
 0.00 1.91 1.70 2.13 4.10
Price-to-Book (P/B) Ratio
 0.96 0.94 0.82 0.84 0.54
Price-to-Free Cash Flow (P/FCF) Ratio
 0.00 -10.99 -124.02 -12.89 -4.89
Price-to-Operating Cash Flow Ratio
 -12.03 -11.77 -229.74 -15.79 -7.62
Price-to-Earnings Growth (PEG) Ratio
 -0.69 0.43 -0.04 0.24 0.14
Price-to-Fair Value
 0.96 0.94 0.82 0.84 0.54
Enterprise Value Multiple
 0.35 -8.49 -6.88 -26.47 -10.58
Enterprise Value
 -3.00B 126.59B 126.43B 152.13B 139.26B
EV to EBITDA
 0.35 -8.49 -6.88 -26.47 -10.58
EV to Sales
 -0.04 1.87 1.63 2.00 5.23
EV to Free Cash Flow
 0.25 -10.74 -118.92 -12.11 -6.24
EV to Operating Cash Flow
 0.27 -11.50 -220.29 -14.83 -9.72
Tangible Book Value Per Share
 1.74K 1.74K 1.98K 2.23K 3.03K
Shareholders’ Equity Per Share
 1.78K 1.78K 2.03K 2.28K 3.06K
Tax and Other Ratios
Effective Tax Rate
 <0.01 <0.01 >-0.01 0.05 0.02
Revenue Per Share
 874.65 874.66 981.80 896.84 403.86
Net Income Per Share
 -234.08 -234.08 -280.50 -110.00 -380.44
Tax Burden
 0.99 0.99 1.00 0.94 0.98
Interest Burden
 1.67 1.01 1.01 1.07 1.65
Research & Development to Revenue
 0.05 0.05 0.06 0.07 0.25
SG&A to Revenue
 0.17 0.08 0.08 0.08 0.17
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 <0.01 -0.01
Income Quality
 0.61 0.61 0.03 1.09 0.57
Currency in KRW